These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36925795)

  • 1. Multi-Criteria Decision Analysis to Prioritize People for COVID-19 Vaccination When Vaccines Are in Short Supply.
    Chaker Masmoudi H; Rhili A; Zamali I; Ben Hmid A; Ben Ahmed M; Khrouf MR
    Front Health Serv; 2022; 2():760626. PubMed ID: 36925795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Development of a Tool for Prioritizing Patients with Coronavirus Disease 2019 for Intensive Care.
    Roy M; Hansen P; Sullivan T; Ombler F; Kiore M; Stapleton A; Carr C
    Crit Care Explor; 2021 Mar; 3(3):e0368. PubMed ID: 33786444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage.
    De Nardo P; Gentilotti E; Mazzaferri F; Cremonini E; Hansen P; Goossens H; Tacconelli E;
    Int J Infect Dis; 2020 Sep; 98():494-500. PubMed ID: 32619766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Choice-framework for Covid vaccines in India using a multi-criteria decision analysis approach.
    George TK; Nair NP; Singh AK; Dilesh Kumar A; Roy AD; Mohan VN; Kang G
    Vaccine; 2023 Jun; 41(25):3755-3762. PubMed ID: 37183072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extended picture fuzzy multicriteria group decision analysis with different weights: A case study of COVID-19 vaccine allocation.
    Almulhim T; Barahona I
    Socioecon Plann Sci; 2023 Feb; 85():101435. PubMed ID: 36187871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creating a priority list of non-communicable diseases to support health research funding decision-making.
    Babashahi S; Hansen P; Sullivan T
    Health Policy; 2021 Feb; 125(2):221-228. PubMed ID: 33357963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt.
    Elezbawy B; Fasseeh AN; Németh B; Gamal M; Eldebeiky M; Refaat R; Taha A; Rabiea S; Abdallah M; Ramadan S; Noaman H; Eldin AB; Mostafa H; Nouh S; Zaki A; Abdelrahman M; Abaza S; Kalò Z
    BMC Med Inform Decis Mak; 2022 Nov; 22(1):289. PubMed ID: 36352382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rapid Literature Review of Multi-Criteria Decision Support Methods in the Context of One Health for All-Hazards Threat Prioritization.
    Zhao J; Smith T; Lavigne M; Aenishaenslin C; Cox R; Fazil A; Johnson A; Sanchez J; Hermant B
    Front Public Health; 2022; 10():861594. PubMed ID: 35493347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEF: Multidimensional Examination Framework for Prioritization of COVID-19 Severe Patients and Promote Precision Medicine Based on Hybrid Multi-Criteria Decision-Making Approaches.
    Abdulkareem KH; Al-Mhiqani MN; Dinar AM; Mohammed MA; Al-Imari MJ; Al-Waisy AS; Alghawli AS; Al-Qaness MAA
    Bioengineering (Basel); 2022 Sep; 9(9):. PubMed ID: 36135003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prioritizing Healthcare Interventions: A Comparison of Multicriteria Decision Analysis and Cost-Effectiveness Analysis.
    Wilson R; Chua J; Pryymachenko Y; Pathak A; Sharma S; Abbott JH
    Value Health; 2022 Feb; 25(2):268-275. PubMed ID: 35094800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field testing of a multicriteria decision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa.
    Miot J; Wagner M; Khoury H; Rindress D; Goetghebeur MM
    Cost Eff Resour Alloc; 2012 Feb; 10(1):2. PubMed ID: 22376143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.
    Tatapudi H; Das R; Das TK
    BMC Med Res Methodol; 2021 Dec; 21(1):272. PubMed ID: 34865617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals - an application on improving tender decision making in Indonesia.
    Inotai A; Brixner D; Maniadakis N; Dwiprahasto I; Kristin E; Prabowo A; Yasmina A; Priohutomo S; Németh B; Wijaya K; Kalo Z
    BMC Health Serv Res; 2018 Dec; 18(1):1003. PubMed ID: 30594250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioethical Concerns During the COVID-19 Pandemic: What Did Healthcare Ethics Committees and Institutions State in Spain?
    Ruiz-Hornillos J; Hernández Suárez P; Marín Martínez JM; de Miguel Beriain Í; Nieves Vázquez MA; Albert M; Herrera Abián M; Pacheco-Martínez PA; Trasmontes V; Guillén-Navarro E
    Front Public Health; 2021; 9():737755. PubMed ID: 34722445
    [No Abstract]   [Full Text] [Related]  

  • 18. Priority setting in the Brazilian emergency medical service: a multi-criteria decision analysis (MCDA).
    Frazão TDC; Santos AFAD; Camilo DGG; da Costa Júnior JF; de Souza RP
    BMC Med Inform Decis Mak; 2021 May; 21(1):151. PubMed ID: 33957933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening.
    Cunich M; Salkeld G; Dowie J; Henderson J; Bayram C; Britt H; Howard K
    Patient; 2011; 4(3):153-62. PubMed ID: 21766911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying Multi-Criteria Decision Analysis (MCDA) Simple Scoring as an Evidence-based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets.
    Brixner D; Maniadakis N; Kaló Z; Hu S; Shen J; Wijaya K
    Value Health Reg Issues; 2017 Sep; 13():1-6. PubMed ID: 29073981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.